Slash Boxes

SoylentNews is people

posted by mrpg on Wednesday July 04 2018, @06:19AM   Printer-friendly
from the smoking-is-bad dept.

Submitted via IRC for AndyTheAbsurd

"Leon" is a young Brazilian man who has long struggled with depression. He keeps an anonymous blog, in Portuguese, where he describes the challenge of living with a mental illness that affects some 300 million people worldwide, according to the World Health Organization.

Leon is among the roughly 30 percent of those patients with treatment-resistant depression. Available antidepressant drugs like selective serotonin reuptake inhibitors do not alleviate his depressed mood, fatigue, anxiety, low self-esteem and suicidal thoughts.

A new study may offer hope for Leon and others like him.

Our team of Brazilian scientists has conducted the first randomized, placebo-controlled clinical trial of ayahuasca – a psychedelic drink made of Amazonian plants. The results, recently published in the journal Psychological Medicine, suggest that ayahuasca can work for hard-to-treat depression.

Source: Amazonian psychedelic may ease severe depression, new study shows

Original Submission

This discussion has been archived. No new comments can be posted.
Display Options Threshold/Breakthrough Mark All as Read Mark All as Unread
The Fine Print: The following comments are owned by whoever posted them. We are not responsible for them in any way.
  • (Score: 2, Interesting) by Anonymous Coward on Wednesday July 04 2018, @06:34AM (5 children)

    by Anonymous Coward on Wednesday July 04 2018, @06:34AM (#702399)

    Another name for Ayahuasca is yagé, pronounced yah-hay (sometimes written as yahe).
    Back in 1982, integrative medicine guy [] Andrew Weil MD [] did a 1 hour and 45 minute presentation called "The Use and Abuse of Beneficial Plants" in which, using a slide show, he describes his trip to South America in search of folks doing that stuff.

    In January 2018, once again, Roy Tuckman (Roy of Hollywood) featured a recording of that on his midnight-to-6AM KPFA program "Something's Happening".

    Weil noted that a typical part of the use of the drug is puking.
    TFA mentions that fact and that they induced that side effect in the control group in their studies.

    About the source page: I really dislike the way TheConversation uses vertical space on their pages.
    As an example, in the Authors area they put the person's name but don't put his credentials/affiliations on the same line.
    They don't even do a simple linefeed; they make that stuff a new paragraph.
    Stupid page building.

    Social media crap also irritates me, especially when it eats up vertical space.

    Protip: Anything you're thinking about putting between the page title and the start of the content that doesn't add directly to the understanding of the topic needs to be somewhere else.

    Oh, and if the very first thing on your page isn't the headline, then the very first on your page should be a Skip to Content link.
    Most folks aren't even slightly interested in your self-promotion and/or site navigation bullshit.

    -- OriginalOwner_ []

    Starting Score:    0  points
    Moderation   +2  
       Interesting=2, Total=2
    Extra 'Interesting' Modifier   0  

    Total Score:   2  
  • (Score: 5, Insightful) by takyon on Wednesday July 04 2018, @07:05AM (3 children)

    by takyon (881) <{takyon} {at} {}> on Wednesday July 04 2018, @07:05AM (#702410) Journal

    Invest in a mouse with a scroll wheel that glides, and you will be wasting mere milliseconds with this vertical space problem.

    One of the primary active components of ayahuasca [] is DMT. Unlike the ~10 minute "businessman's trip" that you get by smoking or injecting DMT, ayahuasca lasts longer but is said to have milder effects. It seems that an IV drip of DMT [] could mimic this experience, probably with less vomiting too. That delivery method could cut down on the ayahuasca tourism if it ever catches on.

    [SIG] 10/28/2017: Soylent Upgrade v14 []
    • (Score: 2) by Mykl on Wednesday July 04 2018, @07:19AM (2 children)

      by Mykl (1112) on Wednesday July 04 2018, @07:19AM (#702420)

      I dunno - it sounds like we're assuming that the puking is a symptom and not the 'active ingredient' in the cure.

      I propose a study the examine the effect of regular vomiting against depression. I suspect that you could easily find your participants (and the chemical means) in any college fraternity...

      • (Score: 2) by takyon on Wednesday July 04 2018, @07:40AM

        by takyon (881) <{takyon} {at} {}> on Wednesday July 04 2018, @07:40AM (#702425) Journal

        There are several psychedelic substances that have been investigated for depression treatment, including ketamine [] (approval could be imminent []), psilocybin [], MDMA [], LSD [], mescaline/peyote [], etc. These substances could also help people to laugh at bad jokes.

        [SIG] 10/28/2017: Soylent Upgrade v14 []
      • (Score: 4, Interesting) by JoeMerchant on Wednesday July 04 2018, @11:49AM

        by JoeMerchant (3937) on Wednesday July 04 2018, @11:49AM (#702500)

        Sometimes a side effect is just a side effect, in this case they're related, but I would hope that the study shows a stronger depression reduction response for ayahuasca than for their ipecac control group.

        Vomiting involves strong stimulation of the vagus, and apparently bulimia is (for many sufferers) an addiction to this stimulation - one which can be replaced with electrical stimulation of the vagus [].

        There has been a lot of study (and application) of VNS as a treatment for depression [] - if that's what you're looking for, I'd suggest going the electro-stim route rather than washing your upper GI tract with stomach acid on a regular basis.

        Україна досі не є частиною Росії. Слава Україні 🌻
  • (Score: 2) by legont on Thursday July 05 2018, @02:04AM

    by legont (4179) on Thursday July 05 2018, @02:04AM (#702793)

    Sting describes it well in his memoirs [] and some interviews.

    "Wealth is the relentless enemy of understanding" - John Kenneth Galbraith.